Espacio reservado para banners y logos institucionales

SABER UCV >  1) Investigación >  Artículos Publicados > 

> Application of the AACE/ACE advanced framework for the diagnosis of obesity and cardiometabolic disease staging in a general population from three regions of Venezuela: the vemsols study results.
Please use this identifier to cite or link to this item: https://saber.ucv.ve/handle/10872/17140

Title: Application of the AACE/ACE advanced framework for the diagnosis of obesity and cardiometabolic disease staging in a general population from three regions of Venezuela: the vemsols study results.
Authors: Rísquez Parra, Alejandro
Nieto-Martínez, Ramfis
González-Rivas, Juan P.
Ugel, Eunice
Brajkovich, Imperia
Garvey, W. Timothy
Mechanick, Jeffrey I.
Keywords: Venezuela
Obesity
Overweight
Prevalence
Framework
Body Fat
Issue Date: 20-Nov-2017
Series/Report no.: ENDOCRINE PRACTICE;EP161644.OR Rapid Electronic Article in Press
Abstract: Objective: To determine the prevalence of obesity according to the AACE/ACE framework based on a complications-centric model with further application of the Cardiometabolic Disease Staging (CMDS) system in Venezuelan population. Methods: 1,320 adults were randomly selected from 3 regions. AACE/ACE framework definitions: overweight: body mass index (BMI) 25 to 29.9 kg/m2 and no obesity-related complications (ORC); obesity stage 0: BMI ≥ 30 and no ORC; stage 1: BMI ≥ 25 and one or more mild-to-moderate ORC; and stage 2: BMI ≥ 25 and one or more severe ORC. CMDS definitions: stage 0: no metabolic syndrome (MS) components; stage 1: 1- 2 MS components without impaired fasting glucose [IFG]; stage 2: IFG, or ≥ 3 MS components but without IFG; stage 3: IFG and MS; and stage 4: type-2 diabetes or cardiovascular disease. Results: Mean age was 44.8±0.4 years and 68.5% were females. The prevalence of obesity according to the AACE/ACE framework was 63.5%: overweight 3.0% (95% CI: 2.1 - 3.9); obesity stage 0: 0.1% (0.07 - 0.27); obesity stage 1: 26.6% (24.2 – 29.0); and obesity stage 2: 36.4% (33.8 - 39.0). Most of the subjects with BMI < 25 were CMDS 0 or 1. In those with BMI ≥ 25, only 4.6% were CMDS 0. The prevalence of obesity according to the WHO (BMI ≥ 30) was 29.3% (24.7 - 33.7). Conclusion: In a general population study, applying the AACE/ACE framework for obesity and CMDS increased the detection of ORC and therefore higher risk subjects compared to classic anthropometric measurements.
URI: http://hdl.handle.net/10872/17140
ISSN: DOI:10.4158/EP161644.OR © 2017 AACE.
Appears in Collections:Artículos Publicados

Files in This Item:

File Description SizeFormat
ep161644.or.pdf907.22 kBAdobe PDFView/Open
View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.